Vuxen Group (VUXEN) Q1 26/27 earnings summary

Executive summary

• Net sales for Q1 2026/27 reached SEK 66.3 million, up 27.0% year-over-year, with EBITDA rising 86.6% to SEK 8.6 million and an EBITDA margin of 12.9%.

• Gross margin improved to 61.2% from 58.0%, reflecting a higher share of proprietary brands and focused purchasing.

• Cash flow for the quarter was SEK 16.2 million, and cash and cash equivalents at period-end totaled SEK 53.5 million.

• The company expanded into Austria post-quarter, leveraging its established German platform and infrastructure.

Financial highlights

• Net sales: SEK 66.3 million (Q1 25/26: SEK 52.2 million), up 27.0% year-over-year.

• Gross profit: SEK 40.6 million (Q1 25/26: SEK 30.3 million), gross margin 61.2% (58.0%).

• EBITDA: SEK 8.6 million (Q1 25/26: SEK 4.6 million), EBITDA margin 12.9% (8.8%).

• Operating profit (EBIT): SEK 6.9 million (Q1 25/26: SEK 2.8 million), EBIT margin 10.4% (5.4%).

• Cash flow for the period: SEK 16.2 million (Q1 25/26: SEK 3.0 million).

Outlook and guidance

• Entering Q2 with strong momentum, focusing on preparations for Black Week and Christmas trading.

• Continued investment in marketing and expansion expected to drive further growth.

• The company aims to leverage scalable logistics and strong cash flow to gain market share in the growing sexual health category.